Skin cancer is the most common type of cancer worldwide and current estimates are that 1 in 5 Americans will develop skin cancer in their lifetime. There are many different types of skin cancers; however, the most common are basal cell carcinoma, squamous cell carcinoma, and melanoma. Melanoma accounts for only 1% of all skin cancers but is responsible for the majority of skin cancer deaths in the US.
We agree with the American Academy of Dermatology (AAD) recommendation for annual skin exams. This is necessary for early detection and treatment of skin cancer. For patients with a history of skin cancer, a long history of sun exposure, sunburns or those that are immunocompromised, more frequent monitoring is recommended.
For patients with skin of color, skin cancer surveillance is highly recommended. Early detection and treatment of skin cancer in this population has a remarkable impact on survival rates.
We believe that skin cancer therapy should be tailored and individualized to each patient. Tumor type, location of the skin cancer, age and health of the patient and patient preference are all factors that are important in reaching a therapeutic decision. Some of the commonly used modalities include: Mohs micrographic surgery, excisional surgery, electrodesiccation and curettage, cryosurgery, radiation therapy, immunotherapy (topical and systemic) and chemotherapy (local and systemic).